Skip to content

Minimally Invasive versus Open Lumbar Interbody Fusion Trial (MIOLIFT): a randomized controlled trial for surgical treatment of lumbar spondylolisthesis and foraminal stenosis

Minimally Invasive versus Open Lumbar Interbody Fusion Trial (MIOLIFT): a randomized controlled trial for surgical treatment of lumbar spondylolisthesis and foraminal stenosis - MIOLIFT

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON53233
Enrollment
198
Registered
2023-07-11
Start date
2023-09-01
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal canal stenosis

Interventions

Investigational treatment A. MITLIF group. After receiving antibiotic prophylaxis, the patient is brought under general anaesthesia and positioned in prone position. Tubular retractors are used to

Sponsors

Zuyderland Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Indication for MITLIF (minimal invasive transforaminal lumbar interbody fusion) or OTLIF (open transforaminal lumbar interbody fusion) surgery. - Clinical mono uni- or bilateral lumbar radiculopathy or intermittent neurogenic claudication caused by a single level degenerative foraminal stenosis or isthmic, iatrogenic, or degenerative spondylolisthesis gr I or II according to Meyerding classification at level L3L4, L4L5 or L5S1. - Age over 18 years. - Single level degenerative foraminal stenosis or isthmic, iatrogenic, or degenerative spondylolisthesis causing central stenosis on MRI (or CT), of which the anatomical level is corresponding to the clinical syndrome. - Psychosocially, mentally, and physically able to fully comply with this study protocol. - Informed consent prior to this study.

Exclusion criteria

Exclusion criteria: - Previous radiotherapy at the intended surgical level. - (Progressive) motor failure and/or anal sphincter disorders which urges instant intervention. - Active spinal infection. - Immature bone (on-going growth). - Active malignancy. - Pregnancy. - Symptomatic osteoporosis (Current or previous use of bisphosphonates). - Contra-indications for anaesthesia or surgery. - Inadequate command of the Dutch language.

Design outcomes

Primary

MeasureTime frame
Change in quality-adjusted life years (QALY) measured with EQ-5D-5L.

Secondary

MeasureTime frame
Cost-effectiveness measured using the productivity related costs (iPCQ), informal care costs (limited iVICQ) and medical costs (iMCQ). Quality of life measured using the following PROMs: Oswestry Disability Index (ODI), Short Form (36) Health Survey (SF-36), Visual Analogue Scale (VAS) score of back pain and leg pain and Hospital Anxiety Depression Scale (HADS). Complications as a result of surgery, are defined as: dural tear, postoperative infection, deep venous thrombosis, hematoma, hardware failure, neurological deficits and other complications as pneumonia or urinary tract infection. Care-related Quality of life measured using the CarerQol-7D and SRB, included in the limited Valuation of Informal Care Questionnaire (iVICQ). Process evaluation will be performed according to the framework provided by Saunders (19). Interviews will be held with randomly chosen patients and ICG, and the principal investigator to collect qualitative data. Other study parameters Other study parameters are: sex, age, BMI, smoking habits, occurrence of diabetes, diagnosis, level, grade of spondylolisthesis, previous back surgery and ASA classification. Also, perioperative morbidity, assessed with: duration of surgery, intraoperative blood loss, duration of hospitalization.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)